Arcutis Biotherapeutics (ARQT)
(Delayed Data from NSDQ)
$9.10 USD
-0.35 (-3.70%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $9.10 0.00 (0.00%) 6:02 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.65 | 0.00% |
Earnings Summary
For their last quarter, Arcutis Biotherapeutics (ARQT) reported earnings of -$0.72 per share, missing the Zacks Consensus Estimate of -$0.65 per share. This reflects a negative earnings surprise of 10.77%. Look out for ARQT's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.65 per share, reflecting a year-over-year increase of 50.38%.
Earnings History
Price & Consensus
Zacks News for ARQT
Arcutis Biotherapeutics, Inc. (ARQT) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
ARQT: What are Zacks experts saying now?
Zacks Private Portfolio Services